Annual influenza vaccination: Immune response in patients over 10 years

Vaccine

Volumn 14, Issue 13, 1996, Pages 1280-1284

  Gross, Peter A ^a,b   Denning, Carolyn R ^c,d   Gaerlan, Pureza F ^c,d   Bonelli, Joan ^a,b   Bernius, Maureen ^c,d   Dran, Sandra ^a,b   Monk, Gary ^a,b   Vassallo, Mary ^a,b   Quinnan Jr , Gerald V ^e   Levandowski, Roland ^f   Cataruozolo, Patricia E ^a,b   Wallenstein, Sylvan ^g  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c ST VINCENT S HOSPITAL   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INFLUENZA; MALE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION; INFLUENZA VACCINES; MALE; PROSPECTIVE STUDIES;

EID: 0030250360     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00004-7     Document Type: Article

References (27)

1. 1 CDC. Recommendations of the Immunization Practices Advisory Committee. Influenza Vaccines 1982-83 1982, 31, 349-353
2. 2 CDC. Recommendations of the Immunization Practices Advisory Committee. Influenza Vaccines 1983-84 1983, 333-337
3. 3 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1984, 33, 253-266
4. 4 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1985, 34, 261-275
5. 5 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1986, 35, 317-331
6. 6 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1987, 36, 373-387
7. 7 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1988, 37, 361-390
8. 8 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza: part I vaccines. Morbid. Mortal. Wkly Rep. 1989, 38, 297-311
9. 9 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1990, 39, 1-15
10. 10 CDC Recommendations of the Immunization Practices Advisory Committee. Prevention and control of influenza. Morbid. Mortal. Wkly Rep. 1991, 40, 1-15
11. 11 Gross, P.A., Ennis, F.A., Noble, G.R., Gaerlan, P.F., Davis, W.J. and Denning, C.R. Influenza vaccine in unprimed children: improved immunogenicity with few reactions following one high dose of split-product vaccine. J. Pediatr. 1980, 97, 56-60
12. 12 Kendal, A.P. and Dowdle, W.R. Influenza virus. In: Manual of Clinical Laboratory Immunology (Eds Rose, N.R., Friedman, H. and Fahey, J.L.), 3rd edn. American Society for Microbiology, Washington, DC, 1986, pp. 515-520
13. 13 Foy, H.M., Allan, I., Blumhagen, J.M., Cooney, M.K., Hall, C. and Fox, J.P. A/USSR and B/Hong Kong Vaccine. J. Am. Med. Assoc. 1981, 245, 1736
14. 14 Evans, A.S. Influenza and other respiratory infections. In: Serological Epidemiology (Eds Paul, J.R. and White, C.). Academic Press, New York, 1973, pp. 69-81
15. 15 Shwachman, H. and Kulczychki, L.L. Long-term study of one hundred five patients with cystic fibrosis. AMA J. Dis. Child. 1958, 96, 6-15
16. 16 Taussig, L.M., Kattwinkel, J., Friedewald, W.T. and di Sant'Agnese, P.A. A new prognostic score and clinical evaluation system for cystic fibrosis. J. Pediatr. 1973, 83, 380-390
17. 17 SAS Institute Inc, SAS Technical Report P-229, SAS/STAT. software, Changes and Enhancements, Release 6.07, SAS Institute, Cary NC, 1992
18. 18 Fost, N. and Farrell, P.M. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin. Res. 1989, 37, 495-500
19. 19 Wang, E.E.L., Prober, C.G., Manson, B., Cory, M. and Levinson, H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N. Engl. J. Med. 1984, 311, 1653-1658
20. 20 Efthimiou, J., Hodson, M.E., Taylor, G. and Batten, J.C. Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with CF. Thorax 1984, 39, 150-154
21. 21 Wright, P.F., Khaw, K.T., Oxman, N. and Swachman, H. Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J. Infect. Dis. 1976, 134, 144-149
22. 22 Huang, N.N., Schidlow, D.V., Szatrowski, T.H. et al. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am. J. Med. 1987, 82, 871-879
23. 23 Gross, P.A., Denning, C.R., Gaerlan, P.F. et al. Benefit of annual influenza immunization in patients with cystic fibrosis. In: Options for the Control of Influenza II (Eds Hannoun, C., Kendal, A.P., Klenk, H.D. and Ruben, F.L.). Excerpta Medica, Amsterdam, 1993, pp. 417-421
24. 24 Hoskins, T.W., Davis, J.R., Smith, A.J., Miller, C.L. and Allchin, A. Assessment of inactivated influenza A vaccine after three outbreaks of influenza at Christ's Hospital. Lancet 1979, 1, 33-35
25. 25 Gross, P.A., Hermogenes, A.W., Sacks, H.S., Lau, J. and Levandowski, R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 1995, 123, 518-527
26. 26 Keitel, W.A., Cate, T.R. and Couch, R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 1988, 127, 353-364
27. 27 Gruber, W.C., Campbell, P.W., Thompson, J.M., Reed, G.W., Roberts, B. and Wright, B. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J. Infect. Dis. 1994, 169, 241-247